Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.
Lancet Gastroenterol Hepatol
; 5(8): 753-764, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-32416764
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Benzenesulfonates
/
Carcinoma, Pancreatic Ductal
/
Optical Imaging
/
Antineoplastic Agents, Immunological
/
Panitumumab
/
Indoles
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Lancet Gastroenterol Hepatol
Year:
2020
Type:
Article
Affiliation country:
United States